首页> 美国卫生研究院文献>Frontiers in Pharmacology >Design of bilayer tablets using modified Dioscorea starches as novel excipients for immediate and sustained release of aceclofenac sodium
【2h】

Design of bilayer tablets using modified Dioscorea starches as novel excipients for immediate and sustained release of aceclofenac sodium

机译:使用改性薯os淀粉作为新型赋形剂设计的双层片剂用于醋氯芬酸钠的即时和持续释放

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Bilayer tablets of aceclofenac sodium were developed using carboxymethylated white yam (Dioscorea rotundata) starch (CWY) for a fast release layer (2.5, 5.0, and 7.5% w/w), and acid-hydrolyzed bitter yam (Dioscorea dumetorum) starch (ABY) for a sustaining layer (27% w/w). Sodium starch glycolate (SSG) and hydroxypropyl methyl cellulose (HPMC) were used as standards. The starches were characterized using Fourier Transform Infrared spectroscopy (FT-IR), particle size, swelling power, densities and flow analyses. Mechanical properties of the tablets were evaluated using crushing strength and friability while release properties were evaluated using disintegration and dissolution times. Distinctive fingerprint differences between the native and modified starches were revealed by FT-IR. Carboxymethylation produced starches of significantly (p < 0.05) higher swelling and flow properties while acid-modification produced starches of higher compressibility. Bilayer tablets containing ABY had significantly higher crushing strength and lower friability values (p < 0.05) than those containing HPMC. Crushing strength increased while friability values decreased with increase in CWY. Generally tablets containing the modified Dioscorea starches gave faster (p < 0.05) disintegration times and produced an initial burst release to provide the loading dose of the drug from the immediate-release layer followed by sustained release (300 ± 7.56–450 ± 11.55 min). The correlation coefficient (R2) and chi-square (χ2) test were employed as error analysis methods to determine the best-fitting drug release kinetic equations. In vitro dissolution kinetics generally followed the Higuchi and Hixson-Crowell models via a non-Fickian diffusion-controlled release. Carboxymethylated white yam starch and acid-modified bitter yam starch could serve as cheaper alternative excipients in bilayer tablet formulations for immediate and sustained release of drugs respectively, particularly where high mechanical strength is required.
机译:使用羧甲基化白山药(Dioscorea rotundata)淀粉(CWY)制成速释层(2.5%,5.0%和7.5%w / w)和酸水解苦山药(Dioscorea dumetorum)淀粉(ABY)开发醋氯芬酸钠双层片剂)作为支撑层(27%w / w)。淀粉羟乙酸钠(SSG)和羟丙基甲基纤维素(HPMC)被用作标准。使用傅立叶变换红外光谱(FT-IR)对淀粉进行了表征,粒度,溶胀力,密度和流动分析。使用压碎强度和脆性评价片剂的机械性能,而使用崩解和溶解时间评价释放性能。 FT-IR揭示了天然淀粉和改性淀粉之间的独特指纹差异。羧甲基化产生的淀粉具有显着(p <0.05)的溶胀和流动性,而酸改性产生的淀粉具有更高的可压缩性。含有ABY的双层片剂比含有HPMC的双层片剂具有更高的抗碎强度和更低的脆碎度值(p <0.05)。随着CWY的增加,压碎强度增加,而脆性值降低。通常,含有改性薯os淀粉的片剂具有更快的(p <0.05)崩解时间并产生初始突释,以提供从速释层中加载的药物剂量,然后持续释放(300±7.56–450±11.55 min) 。采用相关系数(R 2 )和卡方检验(χ 2 )作为误差分析方法,确定了最合适的药物释放动力学方程。体外溶出动力学通常通过非菲克扩散控制释放遵循Higuchi和Hixson-Crowell模型。在双层片剂中,羧甲基化的白薯淀粉和酸改性的苦薯淀粉可以作为便宜的替代赋形剂,分别用于药物的即时和持续释放,特别是在需要高机械强度的情况下。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号